Pipeline

Multiple Product Candidates Advancing to Clinic in 2018 & 2019

Sutro Biopharma is working independently and with partners to develop novel cancer therapies, including antibody-drug conjugates, bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways.